AtheroNova has entered into an agreement with Frontage Laboratories to commence work on the formulation, compounding and tabletization of the AHRO-001 tablets. Frontage will commence work on the analysis, formulation and validation of the ...
Tags: AtheroNova, AHRO-001, atherosclerosis